Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.8.0.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current Assets    
Cash $ 559,571 $ 22,002
Prepaid expenses 32,900  
Total Current Assets 592,471 22,002
Deferred offering costs   143,199
Cash and marketable securities held in Trust Account 116,247,875  
Total Assets 116,840,346 165,201
Current liabilities    
Account payable and accrued expenses 59,951 1,038
Accrued offering costs 10,000 17,500
Income taxes payable 5,968  
Promissory note - related party   122,839
Total Current Liabilities 75,919 141,377
Commitments  
Common stock subject to possible redemption, 11,061,794 and -0- shares at redemption value as of March 31, 2018 and December 31, 2017, respectively 111,764,426  
Stockholders' Equity    
Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,758,206 and 2,875,000 issued and outstanding (excluding 11,061,794 and -0- shares subject to possible redemption) as of March 31, 2018 and December 31, 2017, respectively 376 288
Additional paid-in capital 4,978,352 24,712
Retained earnings/(Accumulated deficit) 21,273 (1,176)
Total Stockholders' Equity 5,000,001 23,824
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 116,840,346 $ 165,201